MDxHealth SA (MDXH) Misses Q2 EPS by 15c

Go back to MDxHealth SA (MDXH) Misses Q2 EPS by 15c

BTIG Reiterates Buy Rating on MDxHealth SA (MDXH)

August 23, 2024 5:05 AM EDT

BTIG analyst Mark Massaro reiterated a Buy rating and $8.00 price target on MDxHealth SA (NASDAQ: MDXH)

The analyst comments "As pre-announced, MDXH reported a Q2 revenue beat and raised its 2024 revenue guide slightly in excess of the beat, marking another solid quarter of... More